Kynam Capital Management, LP — 13F Holdings & Portfolio

CIK 1907884 · latest 13F-HR filed 2026-08-14

Kynam Capital Management, LP manages $1.81B in 13F-reported U.S. long-equity assets across 32 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are CLDX (10.95%), SNDX (9.73%), PCVX (9.39%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 5 new positions and exited 9; 18 existing positions rose in reported value and 7 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$1.81B

Long-equity book

Holdings
32

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+5 / −9 / ↑18 / ↓7

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 72.7%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Apr 10, 2026.

Assets Under Management
$2.41B
Discretionary
$2.41B
Employees
3
Accounts
3
Phone
(574) 315-9016
Name Title / Status Ownership Type
KELLER, JARED, JOSEPH ControlCHIEF OPERATING OFFICER, CHIEF COMPLIANCE OFFICER
since Mar 2024
Less than 5%Individual
KYNAM CAPITAL MANAGEMENT GP, LLC ControlGENERAL PARTNER
since Oct 2020
Less than 5%Domestic Entity
TANG, YUE, "NMN" ControlLIMITED PARTNER
since Oct 2020
75% or moreIndividual
TANG, YUE, "NMN" Control
Indirect owner via KYNAM CAPITAL MANAGEMENT GP, LLC
MANAGING MEMBER
since Oct 2020
75% or moreIndividual
Ownership & leadership changes · 3 filings with changes since Apr 12, 2021

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Jun 12, 2024 filing
  • ChangedTANG, YUE, "NMN" · title MANAGING MEMBER → LIMITED PARTNER
Mar 28, 2024 filing
  • AddedKELLER, JARED, JOSEPH · CHIEF OPERATING OFFICER, CHIEF COMPLIANCE OFFICER · Less than 5% · control person
  • ChangedTANG, YUE, "NMN" · title CCO & MANAGING MEMBER → MANAGING MEMBER
Jun 24, 2022 filing
  • ChangedTANG, YUE, "NMN" · title MANAGING MEMBER → CCO & MANAGING MEMBER
Apr 12, 2021 filing (earliest on record)
  • ListedKYNAM CAPITAL MANAGEMENT GP, LLC · GENERAL PARTNER · Less than 5% · control person
  • ListedTANG, YUE, "NMN" · MANAGING MEMBER · 75% or more · control person
  • ListedTANG, YUE, "NMN" · MANAGING MEMBER · 75% or more · indirect via KYNAM CAPITAL MANAGEMENT GP, LLC · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Kynam Capital Management, LP Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 CELLDEX THERAPEUTICS INC NEW CLDX 15117B202 $198.1M 10.95% 5,322,908 SH
2 SYNDAX PHARMACEUTICALS INC SNDX 87164F105 $176.0M 9.73% 8,050,959 SH
3 VAXCYTE INC PCVX 92243G108 $169.9M 9.39% 2,922,335 SH
4 COGENT BIOSCIENCES INC COGT 19240Q201 $141.9M 7.84% 3,667,097 SH
5 VERA THERAPEUTICS INC VERA 92337R101 $124.0M 6.85% 2,890,059 SH
6 VIRIDIAN THERAPEUTICS INC VRDN 92790C104 $118.6M 6.55% 6,453,877 SH
7 TRAVERE THERAPEUTICS INC TVTX 89422G107 $113.6M 6.28% 2,000,000 SH
8 BEAM THERAPEUTICS INC BEAM 07373V105 $97.5M 5.39% 2,840,792 SH
9 UROGEN PHARMA LTD URGN M96088105 $89.6M 4.95% 2,434,207 SH
10 LEGEND BIOTECH CORP LEGN 52490G102 $86.7M 4.79% 3,001,205 SH
11 CYTOMX THERAPEUTICS INC. CTMX 23284F105 $81.4M 4.50% 21,703,093 SH
12 RELAY THERAPEUTICS INC RLAY 75943R102 $61.7M 3.41% 3,300,000 SH
13 CULLINAN THERAPEUTICS INC CGEM 230031106 $56.7M 3.13% 3,114,132 SH
14 MBX BIOSCIENCES INC MBX 55287L101 $51.6M 2.85% 934,799 SH
15 IMMUNOCORE HLDGS PLC IMCR 45258D105 $43.7M 2.41% 1,375,000 SH
16 NURIX THERAPEUTICS INC NRIX 67080M103 $29.0M 1.60% 1,194,757 SH
17 SUTRO BIOPHARMA INC STRO 869367201 $29.0M 1.60% 872,558 SH
18 BIOCRYST PHARMACEUTICALS INC BCRX 09058V103 $25.2M 1.39% 2,522,660 SH
19 PHARVARIS N V PHVS N69605108 $22.9M 1.26% 661,795 SH
20 SUMMIT THERAPEUTICS INC SMMT 86627T108 $17.5M 0.97% 1,200,000 SH
21 PRELUDE THERAPEUTICS INC PRLD 74065P101 $12.9M 0.71% 2,415,087 SH
22 INSMED INC INSM 457669307 $10.7M 0.59% 100,000 SH
23 BURNING ROCK BIOTECH LTD BNR 12233L206 $10.5M 0.58% 1,238,563 SH
24 GERON CORP GERN 374163103 $8.8M 0.48% 6,836,318 SH
25 AMARIN CORP PLC AMRN 023111404 $8.5M 0.47% 532,982 SH
26 ALECTOR INC ALEC 014442107 $7.7M 0.42% 3,808,494 SH
27 PARABILIS MEDICINES INC PBLS 698955101 $6.8M 0.38% 250,000 SH
28 CARIBOU BIOSCIENCES INC CRBU 142038108 $4.4M 0.24% 2,503,302 SH
29 PROQR THRAPEUTICS N V PRQR N71542109 $2.9M 0.16% 1,566,317 SH
30 CANDEL THERAPEUTICS INC CADL 137404109 $996.4K 0.06% 96,741 SH
31 ENGENE THERAPEUTICS INC ENGN 29286X101 $792.1K 0.04% 457,855 SH
32 TRAWS PHARMA INC TRAW 68232V884 $71.2K 0.00% 84,400 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $1.81B 32 0001907884-26-000012
2026-03-31 2026-05-15 $1.62B 39 0001907884-26-000007
2025-12-31 2026-02-17 $1.57B 37 0001907884-26-000001
2025-09-30 2025-11-14 $1.34B 35 0001907884-25-000002
Filer Information
Address
221 ELM ROAD
PRINCETON, NJ 08540
Phone
(212) 659-3970
Filing Manager
Kynam Capital Management, LP
PRINCETON, NJ
Signatory
Jared Keller
COO